Yi Xiao

1.9k total citations · 1 hit paper
71 papers, 1.1k citations indexed

About

Yi Xiao is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Yi Xiao has authored 71 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 31 papers in Molecular Biology and 18 papers in Surgery. Recurrent topics in Yi Xiao's work include Colorectal Cancer Surgical Treatments (13 papers), Cancer-related Molecular Pathways (9 papers) and Colorectal and Anal Carcinomas (8 papers). Yi Xiao is often cited by papers focused on Colorectal Cancer Surgical Treatments (13 papers), Cancer-related Molecular Pathways (9 papers) and Colorectal and Anal Carcinomas (8 papers). Yi Xiao collaborates with scholars based in China, United States and Hong Kong. Yi Xiao's co-authors include Jixin Dong, Li Wu, Hua Zhou, Pengju Zhang, Vincent Kam Wai Wong, Liang Liu, Ting Li, Chunli Yin, Zhi‐Hong Jiang and Ding Ma and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Yi Xiao

66 papers receiving 1.1k citations

Hit Papers

Spatial determinants of antibody-drug conjugate SHR-A1811... 2025 2026 2025 5 10 15
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Spatial determinants of antibody-drug conjugate SHR-A1811 efficacy in neoadjuvant treatment for HER2-positive breast cancer
    2025 18 citations Yi Xiao et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi Xiao China 19 668 344 316 135 99 71 1.1k
Yule Chen China 21 726 1.1× 279 0.8× 281 0.9× 265 2.0× 109 1.1× 48 1.1k
Ita Novita Sari South Korea 12 908 1.4× 346 1.0× 516 1.6× 115 0.9× 59 0.6× 19 1.4k
Cuiling Qi China 19 545 0.8× 296 0.9× 346 1.1× 134 1.0× 100 1.0× 44 1.1k
Călin Ionescu Romania 14 814 1.2× 447 1.3× 265 0.8× 126 0.9× 88 0.9× 20 1.3k
Nancy De Nève Belgium 17 490 0.7× 216 0.6× 211 0.7× 114 0.8× 80 0.8× 31 961
Hyunho Yoon South Korea 16 569 0.9× 277 0.8× 365 1.2× 111 0.8× 101 1.0× 30 1.1k
Ming‐Chuan Hsu Taiwan 16 987 1.5× 373 1.1× 330 1.0× 152 1.1× 51 0.5× 24 1.3k

Countries citing papers authored by Yi Xiao

Since Specialization
Citations

This map shows the geographic impact of Yi Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Xiao more than expected).

Fields of papers citing papers by Yi Xiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Xiao. The network helps show where Yi Xiao may publish in the future.

Co-authorship network of co-authors of Yi Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Xiao. A scholar is included among the top collaborators of Yi Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Xiao. Yi Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Bo, Olawale A. Alimi, Yanfei Wang, et al.. (2024). Differentiated mesenchymal stem cells-derived exosomes immobilized in decellularized sciatic nerve hydrogels for peripheral nerve repair. Journal of Controlled Release. 368. 24–41. 20 indexed citations
2.
3.
4.
Chen, Xuejie, et al.. (2024). Global Burden of Inflammatory Bowel Disease Among Children and Adolescents: A Comprehensive Analysis (1990–2019). International Journal of Public Health. 69. 1607440–1607440. 3 indexed citations
5.
6.
Xiao, Yi, et al.. (2024). Opportunities and Perspectives for Three Dimensional Culture of Mesenchymal Stem Cell-Derived Exosomes. Tissue Engineering Part B Reviews. 30(4). 462–476. 5 indexed citations
7.
Wang, Yun, Yanqing Ma, Shaofeng Duan, et al.. (2024). Nomogram using intratumoral and peritumoral radiomics for the preoperative prediction of visceral pleural invasion in clinical stage IA lung adenocarcinoma. Journal of Cardiothoracic Surgery. 19(1). 307–307. 4 indexed citations
8.
Feng, Lei, Yi Wang, Yu Fu, et al.. (2023). A simple and efficient strategy for cell‐based and cell‐free‐based therapies in acute liver failure: hUCMSCs bioartificial liver. Bioengineering & Translational Medicine. 8(5). e10552–e10552. 6 indexed citations
9.
Chen, Xuejie, Yue He, Yi Xiao, et al.. (2023). Pancreatic cancer challenge in 52 Asian countries: age-centric insights and the role of modifiable risk factors (1990-2019). Frontiers in Oncology. 13. 1271370–1271370. 5 indexed citations
10.
Xiao, Yi & Jixin Dong. (2023). Coming of Age: Targeting Cyclin K in Cancers. Cells. 12(16). 2044–2044. 7 indexed citations
11.
Xiao, Yi, Jinyuan He, Min Dong, et al.. (2022). Comparison of Immunotherapy, Chemotherapy, and Chemoimmunotherapy in Advanced Pulmonary Lymphoepithelioma-Like Carcinoma： A Retrospective Study. Frontiers in Oncology. 12. 820302–820302. 14 indexed citations
12.
Xiao, Yi, et al.. (2022). Predicting Pathological Complete Response in Neoadjuvant Dual Blockade With Trastuzumab and Pertuzumab in HER2 Gene Amplified Breast Cancer. Frontiers in Immunology. 13. 877825–877825. 7 indexed citations
13.
Wang, Jue, et al.. (2021). Friedelin inhibits the growth and metastasis of human leukemia cells via modulation of MEK/ERK and PI3K/AKT signalling pathways.. PubMed. 25(3). 1594–1599. 5 indexed citations
14.
Xiao, Yi, et al.. (2021). Survival rates of patients with tumors originating in different segments of the left upper lung in stage I to III non-small cell lung cancer. Annals of Translational Medicine. 9(20). 1590–1590. 1 indexed citations
15.
Xiao, Yi, Yuanhong Chen, Aimin Peng, & Jixin Dong. (2021). The phosphatase CTDSPL2 is phosphorylated in mitosis and a target for restraining tumor growth and motility in pancreatic cancer. Cancer Letters. 526. 53–65. 13 indexed citations
16.
Zhang, Changsheng, et al.. (2019). Identification of hub genes and key pathways associated with angioimmunoblastic T-cell lymphoma using weighted gene co-expression network analysis. SHILAP Revista de lepidopterología. 3 indexed citations
17.
Zhan, Panpan, Yan Hua, Chunli Yin, et al.. (2016). α‐enolase promotes tumorigenesis and metastasis via regulating AMPK/mTOR pathway in colorectal cancer. Molecular Carcinogenesis. 56(5). 1427–1437. 67 indexed citations
18.
Xiao, Yi. (2011). Clinical study on the effect of low molecular weight heparin calcium injection on plasma concentration of edaravone in patients with cerebral infarction. Chinese Journal of Hospital Pharmacy. 1 indexed citations
19.
Xiao, Yi. (2009). Review on Solid State Fermentation of Bio-pesticide. 1 indexed citations
20.
Li, Ting, Vincent Kam Wai Wong, Yi Xiao, et al.. (2009). Pseudolaric acid B suppresses T lymphocyte activation through inhibition of NF‐κB signaling pathway and p38 phosphorylation. Journal of Cellular Biochemistry. 108(1). 87–95. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yule Chen Breakdown of academic impact, for papers by Ita Novita Sari Breakdown of academic impact, for papers by Cuiling Qi Breakdown of academic impact, for papers by Călin Ionescu Breakdown of academic impact, for papers by Nancy De Nève Breakdown of academic impact, for papers by Hyunho Yoon Breakdown of academic impact, for papers by Ming‐Chuan Hsu
Rankless by CCL
2026